-Advertisement-
  About AE   About NHM   Contact Us   Terms of Use   Copyright Info   Privacy Policy   Advertising Policies   Site Map
   
Custom Search of AE Site
spacer spacer

Herpes Vaccine from Soy?

By Sean Henahan, Access Excellence

Baltimore, MD (12/05/98)- The successful production of anti-herpes antibodies in soy plants could represent a cheap and efficient method for creating vaccines, report researchers at Johns Hopkins University.

The researchers genetically modified soybeans to produce human antibodies to herpes simplex virus two, and then compared the activity of the antibodies to those produced by the current standard, mammalian cell culture. In animal studies, the soy-produced antibodies showed similar stability in human semen and cervical mucus, as well as similar efficacy in preventing herpes infection.

Most research with monoclonal antibodies has focused on the therapeutic potential these proteins might provide against cancer and infectious disease. The current research takes a different tack, aiming to produce antibodies that might be used as a vaccine to be applied topically. So far these studies have been conducted only with mice, the scientists believe monoclonal antibodies produced by plants could work well as a cheap and efficient topical lubricant for prevention of herpes worldwide.

"Everybody wants to lower their manufacturing costs, but we're talking about several orders of magnitude of difference in thinking," said Hopkins biophysicist Kevin Whaley. "Right now, people are using the antibodies for therapeutic purposes, and it costs from $200 to $1,000 a dose. We believe we can bring the costs for preventative applications down to pennies per application. As a public health product, this will be the biggest bang for the buck."

Before human trials with the soy-produced proteins can begin, the potential vaccine will have to undergo further safety testing. Following the success with genetically modified soy, the researchers are now working on producing even more effective antibodies in corn, hoping to develop a topical lubricant that could serve to prevent sexually transmitted disease and pregnancy.

"Eventually, these microbicides may merge contraceptive technology with sexually-transmitted disease technology and create the breakthrough we're hoping for in the field of reproductive health," Whaley said. "As costs go down, there will be the move to universal precautions, just like washing your hands after you use the bathroom, brushing your teeth after you eat, and having safe sex."

The research is reported in the December 1998 issue of the journal "Nature Biotechnology."

Related information on the Internet
Vaccines in Vegetable Form
MOAB Production
First MOAB for Cancer

What's News Index

Feedback


 
Today's Health and
BioScience News
Science Update Archives Factoids Newsmaker Interviews
Archive

 
Custom Search on the AE Site

 

-Advertisement-